Review





Similar Products

95
Cell Signaling Technology Inc rabbit anti mouse scd1
Rabbit Anti Mouse Scd1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti mouse scd1/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
rabbit anti mouse scd1 - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

95
Proteintech rabbit anti scd1
Rabbit Anti Scd1, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti scd1/product/Proteintech
Average 95 stars, based on 1 article reviews
rabbit anti scd1 - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti scd1 antibody
Anti Scd1 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti scd1 antibody/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti scd1 antibody - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc rabbit monoclonal anti scd1
Rabbit Monoclonal Anti Scd1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal anti scd1/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
rabbit monoclonal anti scd1 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc scd1
METTL14 mediates lipid metabolism component alterations through <t>SCD1</t> to promote the characteristics of choroidal melanoma metastasis. a , Venn diagram and pathway enrichment analysis identifying SCD1 , HSD17B8 , ELOVL3 , ACSL6 , ACSBG1 , ACADL , and ACAA2 as downstream target candidates of METTL14. b , RM2target ( http://rm2target.canceromics.org/ ) showing the correlation between SCD1 and METTL14 in various cancers. c , Volcano plot showing 315 downregulated and 259 upregulated differential metabolites in SCD1-treated CM cells (MUM-2B) (FC > 1.5, P < 0.05) compared to the control group. d , KEGG enrichment analysis of metabolism pathways associated with differential metabolites. e , Peak area values of Behenic acid and Stearic acid in the unsaturated fatty acid biosynthesis pathway, comparing the shNC group vs. shSCD1 group. f , Free fatty acid colorimetry (NEFA/FFA) showing an increase in free fatty acid content after silencing SCD1. g , Flow cytometry showing ROS levels after silencing SCD1. h-i , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung and liver of mice in two different groups (shNC and shSCD1, n = 5 for each). j-k , Representative images of excised lungs and livers from mice injected with the indicated cells. (Scale bar, 1 cm). l , Representative hematoxylin and eosin (H&E) staining images of lung and liver tissues. m , Immunohistochemical analysis of mouse lung and liver tissues with an anti-SCD1 antibody in two different groups (shNC and shSCD1, n = 5 for each). Scale bar, 50 μm. n , Representative ORO staining images of frozen mouse lung and liver tissues
Scd1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd1/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
scd1 - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc 302 scd1
METTL14 mediates lipid metabolism component alterations through <t>SCD1</t> to promote the characteristics of choroidal melanoma metastasis. a , Venn diagram and pathway enrichment analysis identifying SCD1 , HSD17B8 , ELOVL3 , ACSL6 , ACSBG1 , ACADL , and ACAA2 as downstream target candidates of METTL14. b , RM2target ( http://rm2target.canceromics.org/ ) showing the correlation between SCD1 and METTL14 in various cancers. c , Volcano plot showing 315 downregulated and 259 upregulated differential metabolites in SCD1-treated CM cells (MUM-2B) (FC > 1.5, P < 0.05) compared to the control group. d , KEGG enrichment analysis of metabolism pathways associated with differential metabolites. e , Peak area values of Behenic acid and Stearic acid in the unsaturated fatty acid biosynthesis pathway, comparing the shNC group vs. shSCD1 group. f , Free fatty acid colorimetry (NEFA/FFA) showing an increase in free fatty acid content after silencing SCD1. g , Flow cytometry showing ROS levels after silencing SCD1. h-i , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung and liver of mice in two different groups (shNC and shSCD1, n = 5 for each). j-k , Representative images of excised lungs and livers from mice injected with the indicated cells. (Scale bar, 1 cm). l , Representative hematoxylin and eosin (H&E) staining images of lung and liver tissues. m , Immunohistochemical analysis of mouse lung and liver tissues with an anti-SCD1 antibody in two different groups (shNC and shSCD1, n = 5 for each). Scale bar, 50 μm. n , Representative ORO staining images of frozen mouse lung and liver tissues
302 Scd1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/302 scd1/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
302 scd1 - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc rabbit anti scd1
METTL14 mediates lipid metabolism component alterations through <t>SCD1</t> to promote the characteristics of choroidal melanoma metastasis. a , Venn diagram and pathway enrichment analysis identifying SCD1 , HSD17B8 , ELOVL3 , ACSL6 , ACSBG1 , ACADL , and ACAA2 as downstream target candidates of METTL14. b , RM2target ( http://rm2target.canceromics.org/ ) showing the correlation between SCD1 and METTL14 in various cancers. c , Volcano plot showing 315 downregulated and 259 upregulated differential metabolites in SCD1-treated CM cells (MUM-2B) (FC > 1.5, P < 0.05) compared to the control group. d , KEGG enrichment analysis of metabolism pathways associated with differential metabolites. e , Peak area values of Behenic acid and Stearic acid in the unsaturated fatty acid biosynthesis pathway, comparing the shNC group vs. shSCD1 group. f , Free fatty acid colorimetry (NEFA/FFA) showing an increase in free fatty acid content after silencing SCD1. g , Flow cytometry showing ROS levels after silencing SCD1. h-i , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung and liver of mice in two different groups (shNC and shSCD1, n = 5 for each). j-k , Representative images of excised lungs and livers from mice injected with the indicated cells. (Scale bar, 1 cm). l , Representative hematoxylin and eosin (H&E) staining images of lung and liver tissues. m , Immunohistochemical analysis of mouse lung and liver tissues with an anti-SCD1 antibody in two different groups (shNC and shSCD1, n = 5 for each). Scale bar, 50 μm. n , Representative ORO staining images of frozen mouse lung and liver tissues
Rabbit Anti Scd1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti scd1/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
rabbit anti scd1 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc scd1 216
METTL14 mediates lipid metabolism component alterations through <t>SCD1</t> to promote the characteristics of choroidal melanoma metastasis. a , Venn diagram and pathway enrichment analysis identifying SCD1 , HSD17B8 , ELOVL3 , ACSL6 , ACSBG1 , ACADL , and ACAA2 as downstream target candidates of METTL14. b , RM2target ( http://rm2target.canceromics.org/ ) showing the correlation between SCD1 and METTL14 in various cancers. c , Volcano plot showing 315 downregulated and 259 upregulated differential metabolites in SCD1-treated CM cells (MUM-2B) (FC > 1.5, P < 0.05) compared to the control group. d , KEGG enrichment analysis of metabolism pathways associated with differential metabolites. e , Peak area values of Behenic acid and Stearic acid in the unsaturated fatty acid biosynthesis pathway, comparing the shNC group vs. shSCD1 group. f , Free fatty acid colorimetry (NEFA/FFA) showing an increase in free fatty acid content after silencing SCD1. g , Flow cytometry showing ROS levels after silencing SCD1. h-i , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung and liver of mice in two different groups (shNC and shSCD1, n = 5 for each). j-k , Representative images of excised lungs and livers from mice injected with the indicated cells. (Scale bar, 1 cm). l , Representative hematoxylin and eosin (H&E) staining images of lung and liver tissues. m , Immunohistochemical analysis of mouse lung and liver tissues with an anti-SCD1 antibody in two different groups (shNC and shSCD1, n = 5 for each). Scale bar, 50 μm. n , Representative ORO staining images of frozen mouse lung and liver tissues
Scd1 216, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd1 216/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
scd1 216 - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

Image Search Results


METTL14 mediates lipid metabolism component alterations through SCD1 to promote the characteristics of choroidal melanoma metastasis. a , Venn diagram and pathway enrichment analysis identifying SCD1 , HSD17B8 , ELOVL3 , ACSL6 , ACSBG1 , ACADL , and ACAA2 as downstream target candidates of METTL14. b , RM2target ( http://rm2target.canceromics.org/ ) showing the correlation between SCD1 and METTL14 in various cancers. c , Volcano plot showing 315 downregulated and 259 upregulated differential metabolites in SCD1-treated CM cells (MUM-2B) (FC > 1.5, P < 0.05) compared to the control group. d , KEGG enrichment analysis of metabolism pathways associated with differential metabolites. e , Peak area values of Behenic acid and Stearic acid in the unsaturated fatty acid biosynthesis pathway, comparing the shNC group vs. shSCD1 group. f , Free fatty acid colorimetry (NEFA/FFA) showing an increase in free fatty acid content after silencing SCD1. g , Flow cytometry showing ROS levels after silencing SCD1. h-i , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung and liver of mice in two different groups (shNC and shSCD1, n = 5 for each). j-k , Representative images of excised lungs and livers from mice injected with the indicated cells. (Scale bar, 1 cm). l , Representative hematoxylin and eosin (H&E) staining images of lung and liver tissues. m , Immunohistochemical analysis of mouse lung and liver tissues with an anti-SCD1 antibody in two different groups (shNC and shSCD1, n = 5 for each). Scale bar, 50 μm. n , Representative ORO staining images of frozen mouse lung and liver tissues

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Novel MAFG-METTL14-SCD1 axis regulates lipid metabolism mediating choroidal melanoma distant metastasis

doi: 10.1186/s13046-025-03595-1

Figure Lengend Snippet: METTL14 mediates lipid metabolism component alterations through SCD1 to promote the characteristics of choroidal melanoma metastasis. a , Venn diagram and pathway enrichment analysis identifying SCD1 , HSD17B8 , ELOVL3 , ACSL6 , ACSBG1 , ACADL , and ACAA2 as downstream target candidates of METTL14. b , RM2target ( http://rm2target.canceromics.org/ ) showing the correlation between SCD1 and METTL14 in various cancers. c , Volcano plot showing 315 downregulated and 259 upregulated differential metabolites in SCD1-treated CM cells (MUM-2B) (FC > 1.5, P < 0.05) compared to the control group. d , KEGG enrichment analysis of metabolism pathways associated with differential metabolites. e , Peak area values of Behenic acid and Stearic acid in the unsaturated fatty acid biosynthesis pathway, comparing the shNC group vs. shSCD1 group. f , Free fatty acid colorimetry (NEFA/FFA) showing an increase in free fatty acid content after silencing SCD1. g , Flow cytometry showing ROS levels after silencing SCD1. h-i , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung and liver of mice in two different groups (shNC and shSCD1, n = 5 for each). j-k , Representative images of excised lungs and livers from mice injected with the indicated cells. (Scale bar, 1 cm). l , Representative hematoxylin and eosin (H&E) staining images of lung and liver tissues. m , Immunohistochemical analysis of mouse lung and liver tissues with an anti-SCD1 antibody in two different groups (shNC and shSCD1, n = 5 for each). Scale bar, 50 μm. n , Representative ORO staining images of frozen mouse lung and liver tissues

Article Snippet: Subsequently, the samples were maintained at 4 °C overnight with primary antibodies against METTL14 (dilution 1:1000, HPA038002, Sigma-Aldrich), SCD1 (dilution 1:500, 2794 S, CST), and MAFG (dilution 1:500, #ab154318, Abcam).

Techniques: Control, Colorimetric Assay, Flow Cytometry, Injection, Staining, Immunohistochemical staining

METTL14 mediates choroidal melanoma lipid metabolism by inducing SCD1 m 6 A methylation modification. a , Schematic diagram illustrating the METTL14-SCD1 regulatory axis via a specific m 6 A modification-dependent mechanism. b , The SRAMP ( http://www.cuilab.cn/sramp ) predicting the distribution of high-confidence m 6 A methylation sites and scores evaluation for SCD1 mRNA. c , Linear correlation between METTL14 expression and SCD1 expression. d , qRT-PCR analysis showing alterations in SCD1 mRNA levels after METTL14 depletion. e , FISH assay showing the expression and co-localization of METTL14 (green) with SCD1 (red) in CM cells. DAPI (blue) is used as the nuclear marker. Scale bar, 5 μm. f , m 6 A-MeRIP-qPCR assay showing enrichment of SCD1 by m 6 A-specific antibodies. g , ENCORI-CLIP database ( http://starbase.sysu.edu.cn/ ) illustrating the RBP-mRNA interactions between METTL14 and SCD1. h , Double luciferase assay confirming METTL14 directly binds to the 2492 site of SCD1 3’UTR, with mutations at this site. i , Representative western blot images showing SCD1 expression in normal choroidal tissues and CM tissues. j , Immunohistochemical analysis of human normal choroidal and CM tissue samples with the indicated antibodies. Representative images shown. Scale bar, 100 μm. (Normal: n = 10, CM: n = 34). k , Membrane fluidity assay showing changes in cell membrane fluidity after interfering with SCD1 expression in C918 and MUM-2B cells. l , Transmission electron microscopy (TEM) showing lipid droplet reduction and mitochondrial contraction following the silencing of SCD1 in MUM-2B cells. LD, lipid droplet; M, mitochondria. Scale bars, 1 μm

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Novel MAFG-METTL14-SCD1 axis regulates lipid metabolism mediating choroidal melanoma distant metastasis

doi: 10.1186/s13046-025-03595-1

Figure Lengend Snippet: METTL14 mediates choroidal melanoma lipid metabolism by inducing SCD1 m 6 A methylation modification. a , Schematic diagram illustrating the METTL14-SCD1 regulatory axis via a specific m 6 A modification-dependent mechanism. b , The SRAMP ( http://www.cuilab.cn/sramp ) predicting the distribution of high-confidence m 6 A methylation sites and scores evaluation for SCD1 mRNA. c , Linear correlation between METTL14 expression and SCD1 expression. d , qRT-PCR analysis showing alterations in SCD1 mRNA levels after METTL14 depletion. e , FISH assay showing the expression and co-localization of METTL14 (green) with SCD1 (red) in CM cells. DAPI (blue) is used as the nuclear marker. Scale bar, 5 μm. f , m 6 A-MeRIP-qPCR assay showing enrichment of SCD1 by m 6 A-specific antibodies. g , ENCORI-CLIP database ( http://starbase.sysu.edu.cn/ ) illustrating the RBP-mRNA interactions between METTL14 and SCD1. h , Double luciferase assay confirming METTL14 directly binds to the 2492 site of SCD1 3’UTR, with mutations at this site. i , Representative western blot images showing SCD1 expression in normal choroidal tissues and CM tissues. j , Immunohistochemical analysis of human normal choroidal and CM tissue samples with the indicated antibodies. Representative images shown. Scale bar, 100 μm. (Normal: n = 10, CM: n = 34). k , Membrane fluidity assay showing changes in cell membrane fluidity after interfering with SCD1 expression in C918 and MUM-2B cells. l , Transmission electron microscopy (TEM) showing lipid droplet reduction and mitochondrial contraction following the silencing of SCD1 in MUM-2B cells. LD, lipid droplet; M, mitochondria. Scale bars, 1 μm

Article Snippet: Subsequently, the samples were maintained at 4 °C overnight with primary antibodies against METTL14 (dilution 1:1000, HPA038002, Sigma-Aldrich), SCD1 (dilution 1:500, 2794 S, CST), and MAFG (dilution 1:500, #ab154318, Abcam).

Techniques: Methylation, Modification, Expressing, Quantitative RT-PCR, Marker, Luciferase, Western Blot, Immunohistochemical staining, Membrane, Transmission Assay, Electron Microscopy

The METTL14-SCD1 signaling axis regulates lipid metabolism to promote CM invasion and metastasis. a , Radar chart illustrating the top 10 downregulated differential metabolic products obtained from the shNC + shMETTL14 group vs. shNC + shSCD1 group ( P < 0.05). b , Rescue experiments determining cell membrane fluidity by overexpressing SCD1 upon silencing METTL14 in C918 and MUM-2B cells. c , Rescue experiments revealing free fatty acid content treated by overexpression of SCD1 upon silencing METTL14 in MUM-2B cells. d , Flow cytometry detecting ROS levels in the recovery experiment groups. e , Rescue experiments determining the number of lipid droplets after overexpression of SCD1 upon silencing METTL14 in MUM-2B cells. LD, lipid droplet. Scale bars, 5 μm and 1 μm. f-g , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung and liver of mice in three different groups (shNC + pcDH, shM14 + pcDH, and shM14 + SCD1). h , Representative images of excised lungs and livers from mice injected with the indicated cells. Scale bar, 1 cm. i , Representative images of H&E staining of lung and liver tissues. j , Immunohistochemical analysis of mouse lung and liver tissues performed with an anti-METTL14 antibody in three different groups (shNC + pcDH, shM14 + pcDH, and shM14 + SCD1). Scale bars, 50 μm. k , Representative ORO staining images of lung and liver tissues

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Novel MAFG-METTL14-SCD1 axis regulates lipid metabolism mediating choroidal melanoma distant metastasis

doi: 10.1186/s13046-025-03595-1

Figure Lengend Snippet: The METTL14-SCD1 signaling axis regulates lipid metabolism to promote CM invasion and metastasis. a , Radar chart illustrating the top 10 downregulated differential metabolic products obtained from the shNC + shMETTL14 group vs. shNC + shSCD1 group ( P < 0.05). b , Rescue experiments determining cell membrane fluidity by overexpressing SCD1 upon silencing METTL14 in C918 and MUM-2B cells. c , Rescue experiments revealing free fatty acid content treated by overexpression of SCD1 upon silencing METTL14 in MUM-2B cells. d , Flow cytometry detecting ROS levels in the recovery experiment groups. e , Rescue experiments determining the number of lipid droplets after overexpression of SCD1 upon silencing METTL14 in MUM-2B cells. LD, lipid droplet. Scale bars, 5 μm and 1 μm. f-g , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung and liver of mice in three different groups (shNC + pcDH, shM14 + pcDH, and shM14 + SCD1). h , Representative images of excised lungs and livers from mice injected with the indicated cells. Scale bar, 1 cm. i , Representative images of H&E staining of lung and liver tissues. j , Immunohistochemical analysis of mouse lung and liver tissues performed with an anti-METTL14 antibody in three different groups (shNC + pcDH, shM14 + pcDH, and shM14 + SCD1). Scale bars, 50 μm. k , Representative ORO staining images of lung and liver tissues

Article Snippet: Subsequently, the samples were maintained at 4 °C overnight with primary antibodies against METTL14 (dilution 1:1000, HPA038002, Sigma-Aldrich), SCD1 (dilution 1:500, 2794 S, CST), and MAFG (dilution 1:500, #ab154318, Abcam).

Techniques: Membrane, Over Expression, Flow Cytometry, Injection, Staining, Immunohistochemical staining

SCD1 inhibitor aramchol exhibits diet-dependent anti-metastatic effects. a , Representative multiplexed immunohistochemistry staining images of human normal choroidal tissue and CM tissue samples showing METTL14 (yellow), MAFG (purple), SCD1 (green), and DAPI (blue). b , Schematic representation of the therapy schedule. Mice were acclimated to the cages for 3 days, during which they were all fed normal chow (brown-color pellets). Following acclimation, the mice were divided into three dietary groups: normal-fat diet (NFD), high-fat diet rich in stearate (S-HFD), and high-fat diet rich in oleic acid (O-HFD). The interventions began 3 days prior to injection and continued throughout the study ( n = 5). c , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung of mice in four different groups. d , Representative images of excised lungs from mice injected with the indicated cells. Scale bar, 1 cm. e , Representative H&E staining images of lung tissues

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Novel MAFG-METTL14-SCD1 axis regulates lipid metabolism mediating choroidal melanoma distant metastasis

doi: 10.1186/s13046-025-03595-1

Figure Lengend Snippet: SCD1 inhibitor aramchol exhibits diet-dependent anti-metastatic effects. a , Representative multiplexed immunohistochemistry staining images of human normal choroidal tissue and CM tissue samples showing METTL14 (yellow), MAFG (purple), SCD1 (green), and DAPI (blue). b , Schematic representation of the therapy schedule. Mice were acclimated to the cages for 3 days, during which they were all fed normal chow (brown-color pellets). Following acclimation, the mice were divided into three dietary groups: normal-fat diet (NFD), high-fat diet rich in stearate (S-HFD), and high-fat diet rich in oleic acid (O-HFD). The interventions began 3 days prior to injection and continued throughout the study ( n = 5). c , Representative coronal and axial sectional PET images showing the uptake of 18 F-FDG in the lung of mice in four different groups. d , Representative images of excised lungs from mice injected with the indicated cells. Scale bar, 1 cm. e , Representative H&E staining images of lung tissues

Article Snippet: Subsequently, the samples were maintained at 4 °C overnight with primary antibodies against METTL14 (dilution 1:1000, HPA038002, Sigma-Aldrich), SCD1 (dilution 1:500, 2794 S, CST), and MAFG (dilution 1:500, #ab154318, Abcam).

Techniques: Immunohistochemistry, Staining, Injection